🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

529 results for “Teva” Clear

  1. AGEE cream

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule terminated

    1 trial

  2. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  3. AirDuo Digihaler

    Teva Pharma GmbH

    Asthma

    approved other completed

    1 trial

  4. Albuterol eMDPI DS

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  5. Albuterol-HFA-MDI

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  6. Alcohol Wipes vs. No Alcohol Wipes

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  7. Alfacalcidol

    Teva Pharma GmbH

    Accidental Falls

    approved small molecule terminated

    1 trial

  8. Armodafinil

    Teva Pharma GmbH

    Excessive Sleepiness

    approved small molecule completed

    3 trials

  9. Armodafinil

    Teva Pharma GmbH

    Menopause

    approved small molecule completed

    1 trial

  10. Beclomethasone (QVAR)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  11. CELLULOSE, MICROCRYSTALLINE, YOCORAL 5 mg tabletten, Hydrocortison Teva 10 mg, filmomhulde tabletten

    Disc Medicine

    Mimic an acute stress response in humans.

    approved small molecule active

    1 trial

  12. Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  13. Copaxone

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  14. Deutetrabenazine

    Teva Pharma GmbH

    Huntington's Disease

    approved small molecule completed

    1 trial

  15. Deutetrabenazine Oral Capsule

    Teva Pharma GmbH

    Tardive Dyskinesia

    approved small molecule active

    1 trial

  16. Digoxin

    Teva Pharma GmbH

    Heart Failure

    approved small molecule completed

    1 trial

  17. Fentanyl Buccal Tablet (FBT)

    Teva Pharma GmbH

    Cancer Pain

    approved small molecule terminated

    1 trial

  18. Fluticasone propionate/salmeterol (FS)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  19. Foliumzuur Aurobindo 5 mg, tabletten, XELJANZ 5 mg film-coated tablets, METHOTREXAAT SANDOZ 2,5 MG, TABLETTEN, Methotrexaat Teva 20,0 mg, Oplossing voor injectie in een voorgevulde pen, Enbrel 50 mg solution for injection in pre-filled syringe, Methotrexaat Teva 25,0 mg, Oplossing voor injectie in een voorgevulde pen, Methotrexaat Teva 15 mg, Oplossing voor injectie in een voorgevulde pen

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial

  20. Fremanezumab

    Teva Pharma GmbH

    Migraine

    approved small molecule active

    9 trials

  21. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial

  22. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  23. Ketamine

    Teva Pharma GmbH

    Treatment Resistant Depression

    approved small molecule active

    1 trial

  24. Naproxen

    Teva Pharma GmbH

    Menorrhagia

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources